These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23412777)

  • 1. Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.
    Ha SY; Kang SY; Do IG; Suh YL
    J Neurooncol; 2013 May; 112(3):439-48. PubMed ID: 23412777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.
    Laxton RC; Popov S; Doey L; Jury A; Bhangoo R; Gullan R; Chandler C; Brazil L; Sadler G; Beaney R; Sibtain N; King A; Bodi I; Jones C; Ashkan K; Al-Sarraj S
    Neuro Oncol; 2013 Dec; 15(12):1635-43. PubMed ID: 24158110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.
    Wang Y; Li S; Chen L; You G; Bao Z; Yan W; Shi Z; Chen Y; Yao K; Zhang W; Kang C; Jiang T
    Neuro Oncol; 2012 Apr; 14(4):518-25. PubMed ID: 22326863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution.
    Jiang H; Ren X; Wang J; Zhang Z; Jia W; Lin S
    J Neurooncol; 2014 Jan; 116(2):395-404. PubMed ID: 24264532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.
    Figarella-Branger D; Mokhtari K; Colin C; Uro-Coste E; Jouvet A; Dehais C; Carpentier C; Villa C; Maurage CA; Eimer S; Polivka M; Vignaud JM; Laquerriere A; Sevestre H; Lechapt-Zalcman E; Quintin-Roué I; Aubriot-Lorton MH; Diebold MD; Viennet G; Adam C; Loussouarn D; Michalak S; Rigau V; Heitzmann A; Vandenbos F; Forest F; Chiforeanu D; Tortel MC; Labrousse F; Chenard MP; Nguyen AT; Varlet P; Kemeny JL; Levillain PM; Cazals-Hatem D; Richard P; Delattre JY;
    Brain Pathol; 2015 Jul; 25(4):418-28. PubMed ID: 25407774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.
    Appin CL; Gao J; Chisolm C; Torian M; Alexis D; Vincentelli C; Schniederjan MJ; Hadjipanayis C; Olson JJ; Hunter S; Hao C; Brat DJ
    Brain Pathol; 2013 Jul; 23(4):454-61. PubMed ID: 23289977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status.
    Myung JK; Cho HJ; Kim H; Park CK; Lee SH; Choi SH; Park P; Yoon JM; Park SH
    Transl Oncol; 2014 Dec; 7(6):712-9. PubMed ID: 25500080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.
    Ohno M; Narita Y; Miyakita Y; Matsushita Y; Arita H; Yonezawa M; Yoshida A; Fukushima S; Takami H; Ichimura K; Shibui S
    Jpn J Clin Oncol; 2016 Jan; 46(1):31-9. PubMed ID: 26603354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDH1 mutation of gliomas with long-term survival analysis.
    Myung JK; Cho HJ; Park CK; Kim SK; Phi JH; Park SH
    Oncol Rep; 2012 Nov; 28(5):1639-44. PubMed ID: 22922798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastomas with an oligodendroglial component: a pathological and molecular study.
    He J; Mokhtari K; Sanson M; Marie Y; Kujas M; Huguet S; Leuraud P; Capelle L; Delattre JY; Poirier J; Hoang-Xuan K
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):863-71. PubMed ID: 11556543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
    Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
    Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics of glioblastoma with 1p/19q co-deletion.
    Mizoguchi M; Yoshimoto K; Ma X; Guan Y; Hata N; Amano T; Nakamizo A; Suzuki SO; Iwaki T; Sasaki T
    Brain Tumor Pathol; 2012 Jul; 29(3):148-53. PubMed ID: 22736234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.
    Nagasaka T; Gunji M; Hosokai N; Hayashi K; Ikeda H; Ito M; Inao S
    Brain Tumor Pathol; 2007; 24(1):1-5. PubMed ID: 18095137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
    Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
    J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.
    Li S; Yan C; Huang L; Qiu X; Wang Z; Jiang T
    Neuro Oncol; 2012 Jan; 14(1):109-16. PubMed ID: 22039037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
    Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
    Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.
    Klink B; Schlingelhof B; Klink M; Stout-Weider K; Patt S; Schrock E
    Anal Cell Pathol (Amst); 2010; 33(1):37-54. PubMed ID: 20966543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.
    Mizoguchi M; Hata N; Suzuki SO; Fujioka Y; Murata H; Amano T; Nakamizo A; Yoshimoto K; Iwaki T; Sasaki T
    Neuropathology; 2013 Dec; 33(6):652-7. PubMed ID: 23530875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.
    Klink B; Schlingelhof B; Klink M; Stout-Weider K; Patt S; Schrock E
    Cell Oncol (Dordr); 2011 Jun; 34(3):261-75. PubMed ID: 21538026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.